Eli Lilly and Co. and a development partner has canceled clinical trials on an experimental drug to treat multiple sclerosis
after the drug failed to delay progression of the disease in trial patients.
Indianapolis-based Grain Dealers Mutual Insurance Co., one of the largest property-casualty insurers in the state, will
become part of The Main Street America Group, the Jacksonville, Fla.-based company said this morning.
As concern grows among medical providers that health care reform augurs lower payments, St. Francis
Hospital & Health Centers has agreed to absorb a large group of cardiologists that bring lucrative heart patients to its
facilities.
Two chemistry professors at IUPUI are laboring to create the McDonald’s of research laboratories—low-cost and all over the world.
To pay for a shiny new downtown hospital, the parent corporation of Wishard Health Services will commit itself to yearly
debt payments 10 times as high as they are now. But Wishard officials have no doubt they can bear the extra load
because of places like Rosewalk Village, a nursing home that sits on the eastern side of Indianapolis.
If you want to see a physical therapist in Indiana, you must first see a physician for a consultation
and referral. It’s the law. Indiana is one of only six states where patients are denied direct
access to physical therapy treatment, and one of only two states where evaluation without referral is
prohibited.
President Obama recently announced a cooperative initiative where health care industry leaders plan to
work together to reform the ailing health care system. Shortly after that announcement, the national
media machine spawned considerable concern among several health care groups that the cooperative effort might violate
federal antitrust laws for collusion and price fixing among competitors.
The pharmaceutical industry—which for two decades has given twice as much in campaign donations
to Republicans as Democrats—organized a panel composed mostly of Democrats this month in Indianapolis
to argue its position on health care reform.
Favorable article in prestigious journal could draw attention to Carmel biotech startup.
A state law that went into effect July 1 attempts to attract young physicians and mental health practitioners to underserved
areas by forgiving part of their student loans. But Indiana’s budget woes prevented lawmakers from allocating funds
to support the program.
Health care marketers can adapt to, and even use to their advantage, the online search habits of consumers.
Understanding when and why people search for specific health-related terms is vital to attracting more
visitors (i.e. patients) to a Web site.
Biomet Inc. yesterday reported a $170.9 million loss in its fiscal fourth quarter as the result of more than $300 million
in special charges.
The Indianapolis Colts have become one of the first National Football League teams to sell a corporate sponsorship patch
on players’ practice jersey.
Eli Lilly and Co. finally won approval today from U.S. regulators to sell prasugrel, its highly anticipated blood thinner,
according to Bloomberg News.
Carmel-based Conseco Inc., still a bit strapped for cash, brought in a reinsurance company to shoulder some of the risk
of its life insurance policies. Minnesota-based Wilton Reassurance Co. will pay $57.5 million to Conseco as a ceding
commission to co-insure and administer 104,000 policies held by Conseco subsidiaries.
Purdue University researcher Philip Low, also the chief science officer for West Lafayette-based Endocyte Inc., has developed
a prostate cancer “homing device” to help anti-cancer agents specifically target prostate
cancer tumors.
Local businessman J.B. Carlson contends the $15 million life insurance policy he took out on Stephen Hilbert’s mother-in-law
was legitimate, because she served on his firm’s board and was a key decision-maker. The mother-in-law, Germaine
“Suzy” Tomlinson, died at age 74 last September—just 32 months after the policy was issued.
Drugmakers Eli Lilly and Co., Amylin Pharmaceuticals Inc. and Alkermes Inc. said yesterday that the U.S. Food and Drug Administration
has accepted their application for the once-a-week diabetes drug exenatide.
Two Indianapolis benefits consulting firms have finalized their merger, the companies announced this morning. Terms of the
deal between Benefit Associates Inc. and Benefit Consultants Inc., in the works since March, were not disclosed.
Eli Lilly and Co.’s top rising-star drug has been approved by U.S. regulators for a new use, an event that could boost sales of
the medication. Alimta, a lung cancer drug, was approved as a maintenance therapy for non-small cell lung cancer
for certain patients, Lilly announced today.
